205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-73.23%
Both yoy net incomes decline, with MRVL at -210.29%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.44%
Both reduce yoy D&A, with MRVL at -4.42%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
8050.00%
Lower deferred tax growth vs. MRVL's 1009560.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-16.67%
Both cut yoy SBC, with MRVL at -14.88%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
601.24%
Well above MRVL's 1117.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
382.08%
AR growth well above MRVL's 298.42%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-225.64%
Negative yoy inventory while MRVL is 395.44%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
48.94%
A yoy AP increase while MRVL is negative at -29.77%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
346.96%
Growth well above MRVL's 199.82%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
2900.00%
Some yoy increase while MRVL is negative at -903.97%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
12.02%
Some CFO growth while MRVL is negative at -2.15%. John Neff would note a short-term liquidity lead over the competitor.
-24.19%
Negative yoy CapEx while MRVL is 37.01%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
24.19%
Some acquisitions while MRVL is negative at -194.16%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-19.05%
Both yoy lines negative, with MRVL at -2.77%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-14.13%
We reduce yoy sales while MRVL is 24.38%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-25.26%
We reduce yoy other investing while MRVL is 869.48%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-84.02%
We reduce yoy invests while MRVL stands at 647.60%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
113.16%
Issuance growth of 113.16% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-8.62%
Both yoy lines negative, with MRVL at -121.18%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.